Stanford University


Showing 61-80 of 85 Results

  • Walter Park

    Walter Park

    Professor of Medicine (Gastroenterology and Hepatology)

    Current Research and Scholarly InterestsDr. Park's research interests are in the diagnosis and management of pancreatic cysts, acute and chronic pancreatitis. His approach incorporates methods in health services research including the use of observational datasets, cost-effectiveness studies, and the development of clinical cohorts.

  • Gopanandan Parthasarathy

    Gopanandan Parthasarathy

    Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology

    BioDr Nandan Parthasarathy is a hepatologist and physician-scientist in the Department of Gastroenterology and Hepatology at Stanford University.
    After obtaining his medical degree in JIPMER, India, he completed a 2 year clinical research fellowship at Mayo Clinic, following which he completed his residency training at Cleveland Clinic, and GI and transplant hepatology fellowships at Mayo Clinic. During his fellowship, his research work was focused on exploring the immune mechanisms of liver injury in metabolic dysfunction associated steatohepatitis.
    Clinically, he is focused on taking care of patients with MASH, cirrhosis and liver cancer.
    His career goal is to study the gut-immune system-liver injury axis in order to bring novel therapeutics from the bench to bedside in patients with liver disease.

  • Edward A. Pham

    Edward A. Pham

    Instructor, Medicine - Gastroenterology & Hepatology

    BioMy interest in medicine and research was triggered by my mother’s battle with chronic hepatitis C, which made me realize the transformational power of biomedical research in treating patients. Therefore, my career goal is to become a physician scientist in the field of gastroenterology and hepatology dedicated to translating discoveries in the laboratory into novel medical treatment modalities. My research focus is alterations in phosphoinositides signaling and its pathogenesis in cancers of the hepatobiliary and luminal GI tract with the goal to identify novel targets for therapeutic intervention. I also have a particular interest in understanding the interface between chronic viral infection and cancer through studying how the innate and adaptive immune system are perturbed in chronic viral infections

  • Peter Poullos

    Peter Poullos

    Clinical Professor, Radiology
    Clinical Professor, Medicine - Gastroenterology & Hepatology

    BioDr. Poullos is a native of Stockton California. He earned his B.S. at Santa Clara University and M.D. degree at the University of Texas Medical School at Houston, after which he did an Internal Medicine residency at the University of California-San Francisco, finishing in 2002. He stayed at UCSF as a Gastroenterology fellow until 2004. However, after a spinal cord injury, he decided to retrain in Radiology. He did his Radiology residency at Stanford University, where he also completed a fellowship In Body Imaging in 2009. Dr. Poullos is now a faculty member in both the departments of Radiology and Gastroenterology and Hepatology. His clinical practice is at Stanford Medicine, where he specializes in CT, MRI, and ultrasound of the abdomen and pelvis. His interests include radiology of the acute abdomen, hepatobiliary imaging, and colorectal cancer screening.

    Dr. Poullos is the Founder and Co-Chair of the Stanford Medicine Alliance for Disability Inclusion and Equity (SMADIE), a group composed of people with disabilities and their allies at Stanford Medicine. In that role, Dr. Poullos advocates for students and healthcare providers with disabilities and for health equity for disabled patients. He is a Faculty Advisor to the Stanford Medical Students with Disability and Chronic Illness (MSDCI) and the MSDCI National organizations. Dr. Poullos and SMADIE have made significant contributions to the disability community, including starting the Stanford Conference on Disability in Healthcare and Medicine, now in its seventh year, which draws over 1,900 participants from 54 countries. He is the Co-Host of the popular “DocsWithDisabilities” podcast, has spoken internationally on disability access in medicine, and has written and conducted research in the field. One of his proudest achievements is co-creating the Disability in Medicine Mutual Mentorship Program, which serves the needs of disabled medical and healthcare students and practitioners. In 2022, Dr. Poullos received the Stanford President’s Award for Excellence through Diversity.

  • Afrin Kamal Rahman MD MS

    Afrin Kamal Rahman MD MS

    Clinical Associate Professor, Medicine - Gastroenterology & Hepatology

    BioDr. Afrin Kamal Rahman (previously known as Dr. Kamal) is a Clinical Associate Professor of Gastroenterology at Stanford University School of Medicine. Her health services research interests focus on developing and testing communication tools to improve the patient-care provider experience. She has authored 50+ peer reviewed publications and is an NIH funded research. Dr. Rahman is a principal investigator for a K23 grant awarded by the NIDDK to develop and test a mobile health application tool for patients with gastroesophageal reflux disease (GERD).

    Dr. Rahman is co-chair of the Young International Society for Diseases of the Esophagus (ISDE) and serves on several committees as part of American College of Gastroenterology and American Foregut Society. She is also an associate editor for Diseases of the Esophagus and director of the Esophageal Virtual Collaborative, an on-line platform with a mission to discuss complex challenging cases in benign esophageal disease among colleagues cross-nation.

    PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=kamal%2C+afrin&sort=date
    Research website: knowreflux.org

  • Arghavan Salles

    Arghavan Salles

    Clinical Associate Professor, Medicine - Gastroenterology & Hepatology

    BioDr. Salles is a minimally invasive and bariatric surgeon. She completed medical school and residency in general surgery at Stanford prior to completing her fellowship in minimally invasive surgery at Washington University in St. Louis. She stayed on faculty at Washington University for three years prior to moving back to Stanford in 2019.During the pandemic, Dr. Salles has served as a disaster relief physician, caring for patients with COVID in the ICU. Dr. Salles obtained a PhD in education from Stanford University during her residency training, and her research focuses on gender equity, implicit bias, diversity, inclusion, and physician well-being. Her R01 grant from the NIH focuses on sexual harassment. She is a sought-after speaker and has given over 100 national and international invited talks related to gender equity, physician well-being, and weight bias. She currently serves as the Special Advisor for DEI Programs at the Stanford University Department of Medicine where she is a Clinical Associate Professor.

  • Sunny Sandhu, MD

    Sunny Sandhu, MD

    Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology

    BioDr. Sunny Sandhu is a board-certified, fellowship-trained transplant hepatologist at Stanford Health Care. He also serves as a Clinical Assistant Professor in the Department of Medicine, Division of Gastroenterology & Hepatology at Stanford University School of Medicine.

    Dr. Sandhu specializes in managing all aspects of liver disease. He has a particular focus on cirrhosis, liver transplantation, and outreach programs to improve access to care for patients with advanced liver disease.

    Dr. Sandhu’s research focuses on chronic liver diseases and liver transplantation. He has published on various topics including the management of end-stage liver disease and its associated complications, liver transplantation, and organ allocation. He has presented his work at national meetings and contributed to multiple peer-reviewed journals and book chapters in the field.

    Dr. Sandhu is a fellow of the American College of Physicians (ACP) and a member of the American Association for the Study of Liver Diseases (AASLD), American Society of Transplantation (AST), American College of Gastroenterology (ACG), American Society for Gastrointestinal Endoscopy (ASGE), and American Gastroenterological Association (AGA).

  • Pradeep Kumar Siddappa, MD

    Pradeep Kumar Siddappa, MD

    Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology

    BioDr. Pradeep Kumar Siddappa is a board-certified, fellowship-trained gastroenterologist with Stanford Health Care. He is also a clinical assistant professor in the Department of Medicine, Division of Gastroenterology & Hepatology at Stanford University School of Medicine.

    Dr. Siddappa specializes in advanced endoscopy procedures to diagnose and treat gastrointestinal conditions. He focuses on pancreatic care, including acute and chronic pancreatitis, pancreatic cysts, and pancreatic cancer. He uses advanced, minimally invasive methods to help detect pancreatic cancer early and treat people who cannot undergo surgery.

    Dr. Siddappa has studied many gastrointestinal conditions over the years, garnering grant funding and several awards. His primary research examines pancreatic cancer and how to catch it earlier through biomarkers in the pancreatic cyst fluid. He also investigates ways to improve endoscopic and duodenoscopic technology. He has developed new endoscopic techniques for diagnosis and treatment, including endoscopic ultrasound-guided omental fine needle aspiration.

    Dr. Siddappa has published his findings in peer-reviewed journals including the Journal of Gastrointestinal Cancer, Clinical Endoscopy, JGH Open, and the World Journal of Gastrointestinal Endoscopy. He has also shared his research and presented it at conferences around the world, including at the annual Digestive Diseases Week. He has covered topics including new diagnostic markers in pancreatic cyst fluid, narrow band imaging, hepatocellular carcinoma, and pancreatic ductal adenocarcinoma.

    Dr. Siddappa is a member of the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy.

  • Sundeep Singh

    Sundeep Singh

    Clinical Associate Professor, Medicine - Gastroenterology & Hepatology

    BioAfter living and training throughout the country, I am excited to be part of the Stanford team. As a result of both my personal experiences and training, I am passionate about ensuring that patients receive appropriate diagnostic testing and treatment options in order to improve people's quality of life. In collaboration with my amazing colleagues, I am confident in the high quality and easily accessible care we are able to provide to patients across northern California.

    While my interest is most in inflammatory bowel disease, I am also interested in the interaction between mental health, incentives, and emerging therapies in gastroenterology.

  • Sidhartha Sinha

    Sidhartha Sinha

    Assistant Professor of Medicine (Gastroenterology and Hepatology)

    Current Research and Scholarly InterestsThere are two primary and overlapping emphases of my research, both of which are driven and united by needs-based innovation and translational potential:

    (1) Understanding the microenvironment of the inflamed versus normal gut in order to identify better therapeutic targets for people with immune-¬mediated GI disorders. Here, our investigations include understanding the influence and interactions of pharmacologic and dietary interventions on gut microbiome/metabolomic changes and the host immune response. In the context of providing patients with new understanding and solutions for their disease, I have led and advised on the design of both pilot and large clinical trials (including new FDA approved therapies) for anti-inflammatory therapies;

    (2) Applying novel approaches and technologies (including natural language processing, computer vision, and reinforcement learning) to identify and address unmet clinical needs. In this area we have ongoing and published efforts in my lab to validate and develop solutions to pressing clinical needs. We have developed/led new drug delivery technologies with a multidisciplinary team that have shown strong potential in ongoing human IBD clinical trials. My lab has utilized both supervised and unsupervised approaches to analyze social media discourse and unstructured data sets for identifying patient needs that are rarely addressed in clinical settings. We have gained insights into patient perceptions around preventative health interventions, such as health screening and diet, including the dearth of evidence-based dietary recommendations to treat IBD (despite strong patient desire for solutions in this domain).

  • Elsa Sola

    Elsa Sola

    Instructor, Medicine - Gastroenterology & Hepatology

    Current Research and Scholarly InterestsCirrhosis is a common condition and is associated with recurrent complications. Therapeutic options are limited and the management of complications has been similar for the past decades. The only definitive treatment is liver transplantation; however, this is limited by the number of organs and the risk of complications on the waiting list. Patients with cirrhosis present with profound immune disturbances, but to date there are no therapeutic strategies to restore immune responses.

    Dr Sola’s research interest if focused on understanding the mechanisms of immune dysfunction in cirrhosis to guide the development of future therapeutic options. With her research background in Hepatology and Immunology, Dr Sola is using novel techniques to improve the understanding of cirrhosis progression. She is leveraging her skills in human organoids to develop cirrhosis-derived immune organoids as a platform for investigating mechanisms of immune dysfunction and screening new therapeutic options.

  • Irene Sonu

    Irene Sonu

    Clinical Associate Professor, Medicine - Gastroenterology & Hepatology

    BioI am passionate about gut health and strive to provide the best care to my patients. I specialize in complex motility disorders of the gastrointestinal tract. My areas of clinical expertise include achalasia, dysphagia, eosinophilic esophagitis, gastroesophageal reflux disease, gastroparesis, functional dyspepsia, irritable bowel syndrome, and pelvic floor dysfunction. I also see patients in need of fecal microbiota transplant for recurrent C. difficile infection.

  • Sean Paul Spencer, MD,PhD

    Sean Paul Spencer, MD,PhD

    Assistant Professor of Medicine (Gastroenterology and Hepatology)

    BioSean Spencer, MD,PhD is a Gastroenterologist and Physician Scientist at Stanford University working to uncover the role of dietary intake on the gut microbiome and mucosal immune system. Sean obtained his medical degree University of Pennsylvania, earning his PhD studying nutritional immunology with Yasmine Belkaid,PhD at the National Institutes of Health (NIH), after which he moved to Boston for residency training at Massachusetts General Hospital and completed his Gastroenterology training at Stanford University. Sean’s career goal is to study mechanisms by which dietary intake influences our microbiome and immune system to better understand and treat gastrointestinal disease. Sean has launched a microbiome-focused clinical practice at Stanford where he is working to develop novel microbiome diagnostics and microbial medicines.

  • Ankit Srivastava

    Ankit Srivastava

    Instructor, Medicine - Gastroenterology & Hepatology

    Current Research and Scholarly InterestsMy research focuses on deciphering novel molecular crosstalk between epithelial and immune cells in human epithelial cancers and skin aging. My current projects highlight the targetable epithelial-immune axis in aggressive metastatic tumors with perineural invasion- cutaneous squamous cell carcinoma (cSCC) and head and neck squamous cell carcinoma (HNSC). To accomplish this, I imply single-cell transcriptomics and spatial RNA detection methods- multiplex and hiplex RNAscope along with our newly developed novel tumor nerve invasion model. Additionally, I study the regulome of human skin aging (chronological and photo-aging) by investigating the multiome data to recognize molecular underpinnings of aging.

  • Sarah Streett

    Sarah Streett

    Clinical Professor, Medicine - Gastroenterology & Hepatology

    BioDr. Sarah Streett is a Clinical Professor of Medicine, the Director of Inflammatory Bowel Disease Education at Stanford, and she is passionate about taking care of people with IBD. She is a national expert in treating complex IBD and initiated a multi-disciplinary approach to care with colorectal surgery, pediatrics, and nutrition. In 2018 she received the Champion of Hope Award from the Crohn’s and Colitis Foundation and serves on their National Scientific Advisory Committee. Her interests focus on fertility and pregnancy in people with IBD, developing precision approaches to IBD therapy, and the role that the microbiome and diet play in its pathogenesis. She is a primary investigator of the Stanford IBD Registry and has research projects focused on optimizing clinical outcomes in IBD, the role of the microbiota and diet in IBD and pregnancy, and applying new technologies to individualizing therapy for IBD. She is also the primary investigator on multiple industry-sponsored IBD trials.

    Teaching is a top priority for Dr. Streett who feels that mentoring fellows in the development of their careers is a privilege. She has held many national leadership roles in the American Gastroenterological Association, where she has been Chair of the Practice Management and Economics Committee, and currently serves on the Government Affairs Committee. She also an appointed member of the Gastrointestinal Drug Advisory Committee at the FDA. She has represented the interests of gastroenterologists and their patients on Capitol Hill numerous times. Dr. Streett believes strongly in a collaborative approach to give patients personalized care based on the latest therapies for the treatment of IBD and is committed to mentoring the next generation of experts in the field.

  • Natalie Torok

    Natalie Torok

    Professor of Medicine (Gastroenterology and Hepatology)

    Current Research and Scholarly InterestsOur lab is focused on exploring the role of matrix remodeling in disease progression in metabolic dysfunction steatohepatitis (MASH)-related hepatocellular carcinoma and primary sclerosing cholangitis. Our goal is to uncover how biomechanical characteristics of the ECM affect mechano-sensation, and how these pathways could ultimately be targeted. We are also interested in aging and its effects on metabolic pathways in MASH and HCC.